Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

34
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
34
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

2.5K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.5K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

2.5K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.5K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Zebra bodies recognition by artificial intelligence (ZEBRA): a computational tool for Fabry nephropathy.

Scientific reports·2026
Same author

miRquad: first-in-class dPCR multiplex TaqMan™ Advanced clinical research assay for microRNA detection in head and neck cancer.

Journal of experimental & clinical cancer research : CR·2025
Same author

Clinical outcomes in Fabry patients switching to agalsidase beta for renal ineffectiveness of the primary Fabry therapy: a single-centre analysis.

Clinical kidney journal·2025
Same author

Parent, Child, and Provider Perspectives on HPV Vaccination in 4-8-Year-Olds: A Mixed Methods Study.

Journal of cancer education : the official journal of the American Association for Cancer Education·2025
Same author

Is segmental/multifocal onset a distinct presentation of idiopathic adult-onset dystonia?

Journal of the neurological sciences·2025
Same author

Patterns of Left Ventricular Remodeling and Outcomes in Fabry Disease.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography·2025

Related Experiment Video

Updated: May 6, 2026

Measurement of Oxygen Consumption Rate in Acute Striatal Slices from Adult Mice
07:41

Measurement of Oxygen Consumption Rate in Acute Striatal Slices from Adult Mice

Published on: June 8, 2022

4.4K

PINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity.

Graziella Madeo1, Tommaso Schirinzi, Giuseppina Martella

  • 1Department of System Medicine, University of Rome "Tor Vergata", Rome, Italy.

Movement Disorders : Official Journal of the Movement Disorder Society
|October 30, 2013
PubMed
Summary

Heterozygous mutations in the phosphatase and tensin homolog-induced putative kinase 1 (PINK1) gene cause abnormal corticostriatal plasticity and reduced dopamine release in mice, suggesting an early Parkinson's disease endophenotype.

Keywords:
PINK1autosomal recessive Parkinson's diseaseheterozygous mutationsstriatumsynaptic plasticity

More Related Videos

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.7K
The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
15:09

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

16.3K

Related Experiment Videos

Last Updated: May 6, 2026

Measurement of Oxygen Consumption Rate in Acute Striatal Slices from Adult Mice
07:41

Measurement of Oxygen Consumption Rate in Acute Striatal Slices from Adult Mice

Published on: June 8, 2022

4.4K
Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.7K
The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
15:09

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

16.3K

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Mutations in the PINK1 gene cause early-onset Parkinson's disease.
  • The significance of heterozygous PINK1 mutations is debated, though some studies suggest neural plasticity abnormalities.

Purpose of the Study:

  • To investigate corticostriatal synaptic plasticity in heterozygous PINK1 knockout mice.
  • To determine the role of dopamine release in observed plasticity deficits.

Main Methods:

  • Functional analysis of synaptic plasticity in PINK1(+/-) mice.
  • Assessment of dopamine release in the striatum.
  • Pharmacological interventions to restore LTP.

Main Results:

  • PINK1(+/-) mice showed impaired long-term potentiation (LTP) despite normal motor behavior.
  • Reduced dopamine release in the striatum of PINK1(+/-) mice was observed.
  • Pharmacological agents increasing synaptic dopamine restored normal LTP.

Conclusions:

  • Striatal plasticity abnormalities exist in the heterozygous PINK1 state, potentially serving as an endophenotype for Parkinson's disease.
  • These findings offer insights into early disease stages and potential therapeutic targets.